# Patient Care Plan

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Zora Neale Hurston (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ML040-SYN-TD
- Date: 1958-03-09
- Fictional facility: St. Posthumous Health Center
- Fictional author: Lorraine Abernathy-Osei, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

## What we are working on

- She wants to keep teaching, writing and gardening, and to get her breath back **S**
- She cannot afford expensive medicines or extra trips, and food runs short at the end of the month **S**
- She wants her own account of her symptoms to be believed and every choice explained **S**

## Your goals

- Blood pressure below 130/80 mmHg in the clinic and at home within six months. Target: 1958-06-01. Recorded outcome: 126/76 in the clinic; home average 124/74. **S**
- Breathlessness only on heavy exertion and a KCCQ-12 score at least 15 points higher within six months. Target: 1958-10-19. Recorded outcome: KCCQ-12 54 to 78; NYHA class I to II; ankles no longer swell. **S**
- Every medicine affordable: generic 90-day fills, patient assistance until drug coverage begins, Extra Help and the Medicare Savings Program. Target: 1958-06-01. Recorded outcome: Extra Help and the Medicare Savings Program approved; enrolled in a drug plan; dapagliflozin by patient assistance until then. **S**
- Enough food through the month. Target: 1958-06-01. Recorded outcome: SNAP approved and the food pantry at her church; food lasts the month. **S**
- Know the BE FAST signs of stroke and call 911 at once if any appear. Target: 1958-04-06. Recorded outcome: She teaches back the signs and keeps the card by the telephone. **S**

## What we agreed to do

- Respectful, shared decision-making: take her history as given, explain each test and medicine with its reasons and alternatives, write the plan down, and check costs with her before prescribing. Guideline: 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults (2025) **S**
- Cardiology consultation on the day of the two-week visit, with the echocardiogram, to confirm the cause of breathlessness, look for hypertensive heart disease and HFpEF and their mimics, and advise on treatment. Guideline: 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure (2022); 2023 ACC Expert Consensus Decision Pathway on Management of Heart Failure With Preserved Ejection Fraction (2023); CMID: Clinical Monitoring Intelligence Database, hypertension and heart failure monographs (2026) **S**
- Confirm the diagnosis with 24-hour ambulatory blood pressure monitoring today, before the first dose; then home readings twice daily with a validated upper-arm monitor and a large cuff lent by the clinic. Guideline: 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults (2025); CMID: Clinical Monitoring Intelligence Database, hypertension and heart failure monographs (2026) **S**
- Start a two-drug combination for stage 2 hypertension: chlorthalidone 12.5 mg and amlodipine 5 mg every morning, from the morning after the ambulatory monitor is removed, as low-cost generics; target below 130/80 mmHg; less salt, using foods she already eats. Guideline: 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults (2025); CMID: Clinical Monitoring Intelligence Database, hypertension and heart failure monographs (2026) **S**
- Baseline tests: ECG, NT-proBNP, metabolic panel and magnesium, hemoglobin, TSH, hemoglobin A1c, lipids, ALT and urine albumin-to-creatinine ratio; echocardiogram because of raised NT-proBNP, breathlessness and suspected left ventricular hypertrophy. Guideline: 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults (2025); 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure (2022); CMID: Clinical Monitoring Intelligence Database, hypertension and heart failure monographs (2026) **S**
- Stroke and emergency warning signs: BE FAST (balance, eyes, face, arm, speech, time to call 911), and call 911 for chest pain, severe headache with confusion or vision loss, or breathlessness at rest. Guideline: 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults (2025); Signs and Symptoms of Stroke (2026) **S**
- Costs and coverage, with the clinic's community health worker: a SHINE counselor for Extra Help and the Medicare Savings Program; generic medicines in 90-day fills; patient assistance for any brand-only medicine until coverage begins. Guideline: Help with drug costs (Extra Help) (2026); Medicare Savings Programs (2026); SHINE (Serving Health Insurance Needs of Elders), Florida's State Health Insurance Assistance Program (2026) **S**
- Food: the Hunger Vital Sign at intake; help applying for SNAP through ACCESS Florida; the food pantry list. Guideline: The Hunger Vital Sign (2026); SNAP Eligibility (2026); Public Assistance (ACCESS Florida: SNAP, Medicaid and Medicare Savings Programs) (2026) **S**
- Heart failure treatment: dapagliflozin 10 mg daily with sick-day rules; daily weights with a written plan; metabolic panel one to two weeks after each start or dose change, then every three to six months; KCCQ-12 every three to six months. Guideline: 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure (2022); 2023 ACC Expert Consensus Decision Pathway on Management of Heart Failure With Preserved Ejection Fraction (2023); CMID: Clinical Monitoring Intelligence Database, hypertension and heart failure monographs (2026) **S**
- Atorvastatin 20 mg daily for primary prevention, with a lipid panel at four to twelve weeks. Guideline: 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults (2025); CMID: Clinical Monitoring Intelligence Database, hypertension and heart failure monographs (2026) **S**
- Add spironolactone 12.5 mg daily for blood pressure above target and low potassium on chlorthalidone; potassium and creatinine one to two weeks later. Guideline: 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults (2025); 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure (2022) **S**
- Laboratory checks on the day of clinic visits where possible, and rides through the county's transportation program for people without a car when a separate trip is needed. Guideline: CMID: Clinical Monitoring Intelligence Database, hypertension and heart failure monographs (2026) **S**
- Heat plan for the Florida summer: fans and cooling places, water through the day, sick-day rules for chlorthalidone, spironolactone and dapagliflozin, and the energy assistance program's cooling help. Guideline: 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure (2022); Low Income Home Energy Assistance Program (LIHEAP) (2026) **S**

## Follow-up

- 1958-03-09: Establishing care for morning headaches, breathlessness on exertion and ankle swelling, with very high blood pressure: examination, ECG, laboratory tests, 24-hour ambulatory blood pressure monitoring, a two-drug combination, food and medicine-cost screening, and stroke warning signs **S**
- 1958-03-23: Two-week review: ambulatory blood pressure result, echocardiogram, metabolic panel, cardiology consultation the same day, and the diagnosis **S**
- 1958-04-06: Two-week review after dapagliflozin: metabolic panel, blood pressure and potassium, and benefits applications **S**
- 1958-06-01: Eight-week review: blood pressure at home and in the clinic, potassium and kidney function, lipids, KCCQ-12 and drug coverage **S**
- 1958-09-14: Subsequent annual wellness visit **S**
- 1958-10-19: Seven-month review: blood pressure, heart failure status, metabolic panel, stroke prevention and plans for the year **S**

This teaching document does not replace care from a qualified clinician.
